Clinical Trial

Assessment of D-dimer and CRP for Cardiovascular Risk Prediction in Hemodialysis Patients

Study acronym: BIOCARD-HD
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 19, 2025 (before its estimated February 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study aims to assess whether two blood markers - C-reactive protein (CRP) and D-dimer - can help predict cardiovascular complications in patients undergoing regular hemodialysis. Cardiovascular disease is a common and serious problem in dialysis patients, and early detection is important. the study will include 100 adult patients from the Hemodialysis Unit at Assiut University Hospital. Participants will be divided into two groups: those with and those without known heart disease. Each participant will have a one-time blood test to measure CRP and D-dimer levels. In addition, an electrocardiogram (ECG) will be done once to check for signs of heart problems.
Trial Details
NCT Number NCT07130721
Lead Sponsor Assiut University
Conditions End Stage Renal Disease on Dialysis
Enrollment 100 participants
Start Date 2025-11-01
Primary Completion 2026-02-01 (estimated)
Study Completion 2026-05-01 (estimated)
Updated on ClinicalTrials.gov 2025-08-19